We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+39.08%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
AUM
$222M
AUM Growth
-$19.2M
Cap. Flow
-$54.1M
Cap. Flow %
-24.33%
Top 10 Hldgs %
60.52%
Holding
43
New
2
Increased
13
Reduced
14
Closed
8

Top Buys

Rank Stock Value
1
LASR icon
nLIGHT
LASR
+$7.46M
2
DOMO icon
Domo
DOMO
+$5.93M
3
ALNT icon
Allient
ALNT
+$5.56M
4
VPG icon
Vishay Precision Group
VPG
+$3.94M
5
MYO icon
Myomo
MYO
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 51.2%
2 Technology 34.94%
3 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNL icon
1
Personalis
PSNL
$1.26B
$24.4M 10.99%
3,723,958
-244,990
-6% -$1.14M
DOMO icon
2
Domo
DOMO
$174M
$18.7M 8.43%
1,341,518
+589,935
+78% +$5.93M
SCPH
3
DELISTED
scPharmaceuticals
SCPH
$14.7M 6.63%
3,867,523
-228,844
-6% -$710K
ARQ icon
4
Arq
ARQ
$82.4M
$14.3M 6.41%
2,654,486
-115,792
-4% -$507K
VPG icon
5
Vishay Precision Group
VPG
$1.07B
$11.9M 5.35%
423,484
+159,919
+61% +$3.94M
LASR icon
6
nLIGHT
LASR
$3.37B
$11.8M 5.31%
+600,103
New +$7.46M
LPTH icon
7
Lightpath Technologies
LPTH
$594M
$11.2M 5.05%
3,642,377
-40,555
-1% -$101K
BLZE icon
8
Backblaze
BLZE
$705M
$9.95M 4.48%
1,809,096
+96,775
+6% +$492K
GLW icon
9
CALL
Corning
GLW
$108B
$9.2M 4.14%
175,000
VSTM icon
10
Verastem
VSTM
$530M
$8.31M 3.74%
2,003,179
-334,575
-14% -$2.1M
ZVRA icon
11
Zevra Therapeutics
ZVRA
$579M
$8.1M 3.64%
918,893
-519,216
-36% -$4.21M
MYO icon
12
Myomo
MYO
$36.5M
$7.68M 3.45%
3,555,742
+649,053
+22% +$2.35M
ELVA
13
Electrovaya
ELVA
$382M
$7.35M 3.31%
2,155,836
-106,487
-5% -$313K
ALNT icon
14
Allient
ALNT
$1.36B
$7.26M 3.27%
+200,000
New +$5.56M
ELUT icon
15
Elutia
ELUT
$39.8M
$6.83M 3.07%
3,451,025
+69,610
+2% +$141K
COYA icon
16
Coya Therapeutics
COYA
$93.8M
$6.36M 2.86%
1,105,622
-78,158
-7% -$453K
HRTX icon
17
Heron Therapeutics
HRTX
$92.6M
$6.23M 2.8%
3,009,257
+231,057
+8% +$472K
THTX
18
DELISTED
Theratechnologies
THTX
$4.91M 2.21%
2,082,491
-244,078
-10% -$598K
ANGO icon
19
AngioDynamics
ANGO
$596M
$4.71M 2.12%
474,488
RNXT icon
20
RenovoRx
RNXT
$40.2M
$4.56M 2.05%
3,467,275
PYPD icon
21
PolyPid
PYPD
$77.3M
$4.22M 1.9%
1,194,108
+253,727
+27% +$743K
FENC icon
22
Fennec Pharmaceuticals
FENC
$341M
$3.75M 1.69%
452,400
+91,395
+25% +$625K
GRCE
23
Grace Therapeutics
GRCE
$34.5M
$3.35M 1.51%
1,128,497
-193,882
-15% -$516K
IPWR icon
24
Ideal Power
IPWR
$56M
$3.03M 1.36%
668,623
-149,692
-18% -$724K
AMPG icon
25
AmpliTech
AMPG
$120M
$1.92M 0.86%
905,453

Similar funds

AIGH Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, AIGH Capital Management held 43 positions worth $222M, down 8% from $242M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AIGH Capital Management withdrew a net $54.1M in Q2 2025, closing 8 positions and reducing 14 holdings. Its most notable exit was BK Technologies, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 51% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in nLIGHT worth $11.8M.

  • AIGH Capital Management's largest Q2 2025 buy was nLIGHT: 600,103 shares worth $11.8M.
  • AIGH Capital Management added most to Domo in Q2 2025, an estimated $5.93M increase.
  • AIGH Capital Management's biggest Q2 2025 reduction was Intellicheck, cutting an estimated $5.52M.
  • AIGH Capital Management fully exited BK Technologies in Q2 2025, selling an estimated $10.5M.
  • AIGH Capital Management's ten largest holdings make up 61% of its $222M portfolio in Q2 2025.
  • AIGH Capital Management opened 2 new positions and closed 8 in Q2 2025.
  • AIGH Capital Management's portfolio value fell 8% quarter-over-quarter to $222M.

Based on AIGH Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.